New developments in the optometrist’s assessment and treatment of common headaches

Maduabuchukwu Innocent Nkollo, Aghogho Odogu

Abstract


Headache is pain experienced in the head and neck. It varies in types as it is caused by several reasons but is chiefly of two types, primary and secondary headaches. Primary headaches have no known cause, but secondary headaches have several causes. Tension, cluster and Migraine headaches are examples of primary headaches but hormonal, allergies, caffeine, exertional, hypertension, rebound, post-traumatic and headaches of ocular origin are secondary headaches. Primary and secondary headaches have their respective presentations, signs and symptoms. These headaches also have their peculiar management plans which have been addressed in this article. However, it is expected that the Optometrist will carry out the required eye examination procedures and/or prescribe the ideal medications, if need be, to remedy the headache complaint.

 

Received on, 01 December 2024

Accepted on, 02 January 2025

Published on, 30 January 2025


Full Text:

PDF

References


Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan 25;38(1):1–211.

Manzoni GC, Stovner LJ. Epidemiology of headache. In 2010. p. 3–22.

Stovner LJ, Andree C. Prevalence of headache in Europe: A review for the Eurolight project. Vol. 11, Journal of Headache and Pain. 2010.

Longo D, Fauci A, Kasper D, Hauser S, Jameson J., Loscalzo J. Harrison’s Principles of Internal Medicine, 18th Edition. 18th Ed. New York: McGraw-Hill; 2012.

Chowdhury D. Tension type headache. Ann Indian Acad Neurol. 2012;15(5):83.

Freitag F. Managing and Treating Tension-type Headache. Vol. 97, Medical Clinics of North America. 2013.

Ghadiri-Sani M, Silver N. Headache (chronic tension-type). Vol. 2016, BMJ clinical evidence. 2016.

Wei DY, Khalil M, Goadsby PJ. Managing cluster headache. Pract Neurol. 2019;19(6).

Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Vol. 17, The Lancet Neurology. 2018.

Lasaosa SS, Diago EB, Calzada JN, Benito AV. Cardiovascular Risk Factors in Cluster Headache. Pain Medicine. 2016 Dec 29;pnw305.

Edvardsson B. Cluster headache associated with acute maxillary sinusitis. Springerplus. 2013;2(1).

Nesbitt AD, Goadsby PJ. Cluster headache. BMJ. 2012 Apr 11;344(apr11 1):e2407–e2407.

Tfelt-Hansen PC, Tfelt-Hansen J. Nitroglycerin headache and nitroglycerin-induced primary headaches from 1846 and onwards: A historical overview and an update. Vol. 49, Headache. 2009.

Barloese MCJ, Beske RP, Petersen AS, Haddock B, Lund N, Jensen RH. Episodic and Chronic Cluster Headache: Differences in Family History, Traumatic Head Injury, and Chronorisk. Headache. 2020;60(3).

Waung MW, Taylor A, Qualmann KJ, Burish MJ. Family History of Cluster Headache: A Systematic Review. JAMA Neurol. 2020;77(7).

Hoffmann J, May A. Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol. 2018 Jan;17(1):75–83.

Robert D, Gerald F, Joseph J, John M. Headache and other craniofacial pain. In: Bradley’s Neurology in Clinical Practice, 7th Ed. 7TH ed. Philadelphia, PA : Elsevier/Saunders; 2016.

Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Vol. 16, The Lancet Neurology. 2017.

Tonini MC. Gender differences in migraine. Neurological Sciences. 2018 Jun 12;39(S1):77–8.

Karsan N, Goadsby PJ. Imaging the Premonitory Phase of Migraine. Vol. 11, Frontiers in Neurology. 2020.

Laurell K, Artto V, Bendtsen L, Hagen K, Häggström J, Linde M, et al. Premonitory symptoms in migraine: A cross-sectional study in 2714 persons. Cephalalgia. 2016;36(10).

Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, et al. Migraine headache is present in the aura phase : A prospective study. Neurology. 2012;79(20).

Hansen JM, Charles A. Differences in treatment response between migraine with aura and migraine without aura: Lessons from clinical practice and RCTs. Vol. 20, Journal of Headache and Pain. 2019.

Maurya A, Qureshi S, Jadia S, Maurya M. “Sinus Headache”: Diagnosis and Dilemma?? An Analytical and Prospective Study. Indian Journal of Otolaryngology and Head and Neck Surgery. 2019;71(3).

Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: The role of hormones and their impact on vascular diseases. Vol. 13, Journal of Headache and Pain. 2012.

Zduńska A, Cegielska J, Zduński S, Domitrz I. Caffeine for Headaches: Helpful or Harmful? A Brief Review of the Literature. Vol. 15, Nutrients. 2023.

Nowaczewska M, Wiciński M, Kaźmierczak W. The ambiguous role of caffeine in migraine headache: From trigger to treatment. Vol. 12, Nutrients. 2020.

Nappi G, Moskowitz M. Headache. In: Handbook of Clinical Neurology. 1st Ed. Saunders Elsevier, Philadelphia, Pa ; 2010.

González-Quintanilla V, Madera J, Pascual J. Update on headaches associated with physical exertion. Vol. 43, Cephalalgia. 2023.

Arca KN, Halker Singh RB. The Hypertensive Headache: a Review. Curr Pain Headache Rep. 2019 May 14;23(5):30.

Vandenbussche N, Laterza D, Lisicki M, Lloyd J, Lupi C, Tischler H, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. Vol. 19, Journal of Headache and Pain. 2018.

Scher AI, Lipton RB, Stewart WF, Bigal M. Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study. Cephalalgia. 2010;30(3).

Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA. Risk factors for medication-overuse headache: An 11-year follow-up study. the Nord-Trøndelag Health Studies. Pain. 2012;153(1).

He Z, Dong L, Zhang Y, Kong Q, Tan G, Zhou J. Metabolic syndrome in female migraine patients is associated with medication overuse headache: A clinic-based study in China. Eur J Neurol. 2015;22(8).

Roper LS, Nightingale P, Su Z, Mitchell JL, Belli A, Sinclair AJ. Disability from posttraumatic headache is compounded by coexisting posttraumatic stress disorder. J Pain Res. 2017;10.

Levy D, Gruener H, Riabinin M, Feingold Y, Schreiber S, Pick CG, et al. Different clinical phenotypes of persistent post-traumatic headache exhibit distinct sensory profiles. Cephalalgia. 2020;40(7).

Åhman S, Saveman BI, Styrke J, Björnstig U, Stålnacke BM. Long-term follow-up of patients with mild traumatic brain injury: A mixed-methods study. J Rehabil Med. 2013;45(8).

Shaw L, Morozova M, Abu-Arafeh I. Chronic post-traumatic headache in children and adolescents: Systematic review of prevalence and headache features. Vol. 8, Pain Management. 2018.

Mavroudis I, Ciobica A, Luca AC, Balmus IM. Post-Traumatic Headache: A Review of Prevalence, Clinical Features, Risk Factors, and Treatment Strategies. Vol. 12, Journal of Clinical Medicine. 2023.

Kristoffersen ES, Lundqvist C. Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf. 2014 Apr 6;5(2):87–99.

Sergott RC. Headaches associated with papilledema. Curr Pain Headache Rep. 2012;16(4).

Mollica A, Safavifar F, Fralick M, Giacobbe P, Lipsman N, Burke MJ. Transcranial Magnetic Stimulation for the Treatment of Concussion: A Systematic Review. Vol. 24, Neuromodulation. 2021.

Li ML, Zhang F, Chen YY, Luo HY, Quan ZW, Wang YF, et al. A state-of-the-art review of functional magnetic resonance imaging technique integrated with advanced statistical modeling and machine learning for primary headache diagnosis. Vol. 17, Frontiers in Human Neuroscience. 2023.

Hassan M, Asaad T. Tension-type headache, its relation to stress, and how to relieve it by cryotherapy among academic students. Middle East Current Psychiatry. 2020;27(1).

Lipton RB, Croop R, Stock EG, Stock DA, Morris BA, Frost M, et al. Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine. New England Journal of Medicine. 2019;381(2).

Hargreaves R, Olesen J. Calcitonin Gene-Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class. Headache. 2019;59(6).

Dubowchik GM, Conway CM, Xin AW. Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success. Vol. 63, Journal of Medicinal Chemistry. 2020.

Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED]. Neurology. 2012 Apr 24;78(17):1346–53.

Diener H, Freitag F, Danesch U. Safety profile of a special butterbur extract from Petasites hybridus in migraine prevention with emphasis on the liver . Cephalalgia Rep. 2018;1.

Borlak J, Diener HC, Kleeberg-Hartmann J, Messlinger K, Silberstein S. Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review. Front Neurol. 2022 Apr 26;13.

Rosner MS, Feinberg DL, Doble JE, Rosner AJ. Treatment of vertical heterophoria ameliorates persistent post-concussive symptoms: A retrospective analysis utilizing a multi-faceted assessment battery. Brain Inj. 2016;30(3).

Yerry JA, Kuehn D, Finkel AG. Onabotulinum toxin A for the treatment of headache in service members with a history of mild traumatic brain injury: A cohort study. Headache. 2015;55(3).

Hranilovich JA, Legget KT, Dodd KC, Wylie KP, Tregellas JR. Functional magnetic resonance imaging of headache: Issues, best-practices, and new directions, a narrative review. Headache. 2023;63(3).

Grosvenor T. Primary Care Optometry. 5th Edition. Butterworth-Heinemann, Oxford; 2006.

Benjamin WJ. Borish’s Clinical Refraction. Borish’s Clinical Refraction. 2006.




DOI: http://dx.doi.org/10.21622/AMPDR.2025.05.1.1116

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Maduabuchukwu Innocent Nkollo, Aghogho Odogu

Advances in Medical, Pharmaceutical and Dental Research
E-ISSN: 2812-4898
P-ISSN: 2812-488X 

Published by:

Academy Publishing Center (APC)
Arab Academy for Science, Technology and Maritime Transport (AASTMT)
Alexandria, Egypt
ampdr@aast.edu